Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
FDA Drug Recalls
1,590 recalls, newest first
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class I · High risk
Gaia Kratom
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Class II · Moderate risk
fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL
Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.
Class III · Low risk
Enalapril Maleate Tablets USP
Failed Impurities/Degradation Specifications
Class III · Low risk
Enalapril Maleate Tablets USP
Failed Impurities/Degradation Specifications
Class III · Low risk
Rocaltrol (calcitriol)
Subpotency: lower than expected potency result was obtained at the 18 month stability time point.
Class III · Low risk
Calcitriol Oral Solution
Subpotency: lower than expected potency result was obtained at the 18 month stability time point.
Class II · Moderate risk
Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Class II · Moderate risk
Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Class II · Moderate risk
Phenylephrine HCL 20 mg in 0.9% Sodium Chloride 250 mL Bag
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Class II · Moderate risk
Phenylephrine HCL 40 mg in 0.9% Sodium Chloride 250 mL Bag
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Class II · Moderate risk
Phenylephrine HCL 10 mg in 0.9% Sodium Chloride 250 mL Bag
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Class II · Moderate risk
Norepinephrine Bitartrate 16 mg
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.